MATINE CHARLES purchased 683.1% of their position (180.56K shares) of BIONIK LABORATORIES CORP. on the open market
Open‑market purchase worth $108.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/21/2023ACC: 0001104659-23-073230
+180.56K
Net shares
Net buyer
$108.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
180.56K acquired
Non-Derivative Transactions1
Common Stock, par value $0.001 per share
Direct
Shares
+180.56K
Price / share
$0.60
Trade value
$108.33K
% of position
683.1%
6/9/2023
26.43K→206.99K
Total
Net shares
+180.56K
Net value
$108.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Direct | 6/9/2023 | P · Purchase | +180.56K | $0.60 | $108.33K | 683.1% | 26.43K | 206.99K |
| Total | +180.56K | $108.33K | ||||||
Derivative Transactions0
No derivative transactions reported